Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-25-189133
Filing Date
2025-08-27
Accepted
2025-08-27 07:38:53
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 d904071d424b5.htm 424B5 391996
2 GRAPHIC g904071g51v03.jpg GRAPHIC 24805
3 GRAPHIC g904071g65s86.jpg GRAPHIC 39984
4 GRAPHIC g904071g90j12.jpg GRAPHIC 38941
  Complete submission text file 0001193125-25-189133.txt   533532
Mailing Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140
Business Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140 617-655-6580
Vor Biopharma Inc. (Filer) CIK: 0001817229 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-285969 | Film No.: 251259752
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)